Healthcare provider profile · identity verified

Julia M Greenwald, PA-C, ATC

Physician Assistant · INDIAN PURCHASE TWP, ME · NPI 1417151663

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	201	58
Levothyroxine Sodium	Levothyroxine Sodium	157	45
Gabapentin	Gabapentin	136	39
Lisinopril	Lisinopril	136	42
Pantoprazole Sodium	Pantoprazole Sodium	126	41
Losartan Potassium	Losartan Potassium	100	36
Albuterol Sulfate Hfa	Albuterol Sulfate	99	37
Omeprazole	Omeprazole	86	31
Rosuvastatin Calcium	Rosuvastatin Calcium	83	28
Tramadol Hcl	Tramadol Hcl	83	13
Amlodipine Besylate	Amlodipine Besylate	78	27
Trulicity	Dulaglutide	77	16
Ozempic	Semaglutide	65	14
Metformin Hcl	Metformin Hcl	64	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	18
Trazodone Hcl	Trazodone Hcl	62	18
Furosemide	Furosemide	59	18
Metoprolol Succinate	Metoprolol Succinate	59	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	12
Ondansetron Odt	Ondansetron	55	11
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Eliquis	Apixaban	52	12
Famotidine	Famotidine	49	17
Hydrochlorothiazide	Hydrochlorothiazide	45	18
Sertraline Hcl	Sertraline Hcl	45	12
Oxybutynin Chloride Er	Oxybutynin Chloride	43	12
Duloxetine Hcl	Duloxetine Hcl	40	12
Lorazepam	Lorazepam	40	suppressed
Potassium Chloride	Potassium Chloride	40	11
Baclofen	Baclofen	39	suppressed
Glipizide	Glipizide	39	13
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Symbicort	Budesonide/Formoterol Fumarate	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	12
Farxiga	Dapagliflozin Propanediol	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	15
Pravastatin Sodium	Pravastatin Sodium	37	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	12
Nystatin	Nystatin	36	19
Alendronate Sodium	Alendronate Sodium	35	suppressed
Celecoxib	Celecoxib	35	12
Fluticasone Propionate	Fluticasone Propionate	35	12
Ventolin Hfa	Albuterol Sulfate	35	11
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Meclizine Hcl	Meclizine Hcl	34	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	33	suppressed
Mounjaro	Tirzepatide	32	suppressed
Cephalexin	Cephalexin	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	12
Simvastatin	Simvastatin	29	suppressed
Clonazepam	Clonazepam	27	suppressed
Jantoven	Warfarin Sodium	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Prednisone	Prednisone	26	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Rybelsus	Semaglutide	24	11
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Estradiol	Estradiol	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Linzess	Linaclotide	13	suppressed
Lyrica	Pregabalin	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Naproxen	Naproxen	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Atenolol	Atenolol	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error